Abstract
2-Methylthio-ADP and its radioactive analogue [β-32P]2-methylthio-ADP were synthesized and used to investigate platelet receptors for ADP. 2-Methylthio-ADP induced platelet aggregation and shape change, and inhibited cyclic AMP accumulation in platelets exposed to prostaglandin E1. Compared with ADP, 2-methylthio-ADP was 3-5 times as active as an aggregating agent and 150-200 times as active as an inhibitor of cyclic AMP accumulation. Binding of [β-32P]2-methylthio-ADP to platelets was measured after centrifuging them through silicone oil to separate platelets from their suspension medium. Binding was reversible, saturable, and specific, with between 400 and 1,200 sites/cell in different platelet preparations. There was no evidence for a second class of binding sites with different affinity. The second order association rate constant was ~3.5 x 106 M-1 s-1, and the first order dissociation rate was 0.024 s-1, both measured at 23°C. The dissociation equilibrium constant (~15 nM) was about three times higher than the concentration giving half-maximal inhibition of prostaglandin E1-stimulated cyclic AMP accumulation in platelet-rich plasma. Binding was inhibited by ADP (K(i) = 3.5 μM), ATP (7 μM), 2-azido-ADP (0.12 μM), inosine diphosphate (IDP, 150 μM), guanosine diphosphate (GDP, 350 μM), and AMP (800 μM). Binding of 2-methylthio-ADP was also blocked by the noncell-penetrating thiol reagent, p-mercuribenzene sulphonate, a reagent that blocks the inhibition of adenylate cyclase by ADP, but which does not block the ability of ADP to induce aggregation or platelet shape change. The amount of 2-methylthio-ADP bound at saturation was independent of pH in the range 6-8, but the affinity was reduced at pH 6 compared with pH 6.5-8.0. The dissociation constant was not temperature dependent in the range 32°-40° C, whereas the rate of dissociation of 2-methylthio-ADP from platelets after the addition of an excess of ADP approximately doubled over this range. The activation energy for dissociation was ~15 kcal/mol. Our results support the conclusion that platelets have a receptor for ADP, which inhibits cyclic AMP accumulation, and which has a sulphydryl group in the binding pocket.
Cite
CITATION STYLE
Macfarlane, D. E., Srivastava, P. C., & Mills, D. C. B. (1983). 2-Methylthioadenosine[β-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. Journal of Clinical Investigation, 71(3), 420–428. https://doi.org/10.1172/JCI110786
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.